| Symbol: |
RALGAPB
|
| Description: |
Ral GTPase activating protein, beta subunit (non-catalytic) [Source:HGNC Symbol;Acc:29221]
|
| Location: |
Chr20:37101459-37207504[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:76
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| RALGAPB |
6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- |
0.043 |
Up |
| RALGAPB |
NSC 112789 |
0.025 |
Down |
| RALGAPB |
NSC 116878 |
0.036 |
Up |
| RALGAPB |
NSC 11865 |
0.03 |
Up |
| RALGAPB |
NSC 123978 |
0.042 |
Up |
| RALGAPB |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.003 |
Up |
| RALGAPB |
Bromocriptine methanesulfonate |
0.022 |
Up |
| RALGAPB |
NSC 175296 |
0.037 |
Up |
| RALGAPB |
Mitoxantrone |
0.034 |
Up |
| RALGAPB |
Camptothecin ethylglycinate ester hydrochloride |
0.013 |
Up |
| RALGAPB |
Camptothecin hemisuccinate sodium salt |
0.021 |
Up |
| RALGAPB |
NSC 611274 |
0.002 |
Down |
| RALGAPB |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.04 |
Up |
| RALGAPB |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.012 |
Down |
| RALGAPB |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.036 |
Down |
Expression pattern: Sensitivity / Resistance
Total:6 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:73
Total:5 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|